Increased Risk of Death From Iron Overload Among 422 Treated Probands With HFE Hemochromatosis and Serum Levels of Ferritin Greater Than 1000 μg/L at Diagnosis

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 4, 2012, Pages 412-416

  Barton, James C ^a,b   Barton, J Clayborn ^a   Acton, Ronald T ^c   So, Jeffrey ^d   Chan, Susanne ^d   Adams, Paul C ^d  

^a SOUTHERN IRON DISORDERS CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Genetic; Liver disease; Mortality; Prognostic factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FERRITIN; FLUROTHYL; IRON;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANADA; CARDIOMYOPATHY; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; HEART HEMOSIDEROSIS; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; IRON OVERLOAD; LIVER CANCER; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PHLEBOTOMY; RISK FACTOR; SEX RATIO; SURVIVAL TIME;

ADULT; AGED; ALABAMA; AMINO ACID SUBSTITUTION; CARDIOMYOPATHIES; COHORT STUDIES; FEMALE; FERRITINS; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; IRON OVERLOAD; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; ONTARIO; POINT MUTATION; SERUM; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 84858704595     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.11.032     Document Type: Article

References (33)

1. Feder J.N., Gnirke A., Thomas W., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996, 13:399-408.
2. Barton J.C., Acton R.T., Dawkins F.W., et al. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study. Genet Test 2005, 9:231-241.
3. Barton J.C., McDonnell S.M., Adams P.C., et al. Management of hemochromatosis: Hemochromatosis Management Working Group. Ann Intern Med 1998, 129:932-939.
4. Barton J.C., Edwards C.Q., Phatak P.D., et al. Complications of hemochromatosis and iron overload. Handbook of iron overload disorders 2010, 65-107. Cambridge University Press, Cambridge. J.C. Barton, C.Q. Edwards, P.D. Phatak (Eds.).
5. Carroll G.J., Breidahl W.H., Bulsara M.K., et al. Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load. Arthritis Rheum 2011, 63:286-294.
6. Beaton M.D., Adams P.C. Prognostic factors and survival in patients with hereditary hemochromatosis and cirrhosis. Can J Gastroenterol 2006, 20:257-260.
7. Adams P.C., Barton J.C. How I treat hemochromatosis. Blood 2010, 116:317-325.
8. Falize L., Guillygomarc'h A., Perrin M., et al. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology 2006, 44:472-477.
9. Dabestani A., Child J.S., Henze E., et al. Primary hemochromatosis: anatomic and physiologic characteristics of the cardiac ventricles and their response to phlebotomy. Am J Cardiol 1984, 54:153-159.
10. Waalen J., Felitti V.J., Gelbart T., et al. Screening for hemochromatosis by measuring ferritin levels: a more effective approach. Blood 2008, 111:3373-3376.
11. Guyader D., Jacquelinet C., Moirand R., et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998, 115:929-936.
12. Fletcher L.M., Dixon J.L., Purdie D.M., et al. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 2002, 122:281-289.
13. Morrison E.D., Brandhagen D.J., Phatak P.D., et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 2003, 138:627-633.
14. Adams P.C., Reboussin D.M., Barton J.C., et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005, 352:1769-1778.
15. Barton J.C., Harmon L., Rivers C., et al. Hemochromatosis: association of severity of iron overload with genetic markers. Blood Cells Mol Dis 1996, 22:195-204.
16. Witte D.L., Crosby W.H., Edwards C.Q., et al. Practice guideline development task force of the College of American Pathologists: hereditary hemochromatosis. Clin Chim Acta 1996, 245:139-200.
17. Barton J.C., Shih W.W., Sawada-Hirai R., et al. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol Dis 1997, 23:135-145.
18. Scheuer P.J., Williams R., Muir A.R. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol 1962, 84:53-64.
19. Barton J.C., Acton R.T., Anderson L.E., et al. A comparison between whites and blacks with severe multi-organ iron overload identified in 16,152 autopsies. Clin Gastroenterol Hepatol 2009, 7:781-785.
20. Barton J.C., McGuire B.M., Acton R.T. HFE hemochromatosis and hepatic sarcoid. Am J Med Sci 2009, 337:386-390.
21. Barton J.C., Barton J.C., Acton R.T. Longer survival associated with HLA-A*03, B*14 among 212 hemochromatosis probands with HFE C282Y homozygosity and HLA-A and -B typing and haplotyping. Eur J Haematol 2010, 85:439-447.
22. Wojcik J.P., Speechley M.R., Kertesz A.E., et al. Natural history of C282Y homozygotes for hemochromatosis. Can J Gastroenterol 2002, 16:297-302.
23. Beaton M., Adams P.C. Assessment of silent liver fibrosis in hemochromatosis C282Y homozygotes with normal transaminase levels. Clin Gastroenterol Hepatol 2008, 6:713-714.
24. Fletcher L.M., Powell L.W. Hemochromatosis and alcoholic liver disease. Alcohol 2003, 30:131-136.
25. Cheng R., Barton J.C., Morrison E.D., et al. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes. J Clin Gastroenterol 2009, 43:569-573.
26. Hayashi H., Piperno A., Tomosugi N., et al. Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HFE-hemochromatosis. Intern Med 2010, 49:2371-2377.
27. van Dijk B.A., Laarakkers C.M., Klaver S.M., et al. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels. Br J Haematol 2008, 142:979-985.
28. Girelli D., Trombini P., Busti F., et al. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis. Haematologica 2011, 96:500-506.
29. Beutler E., Felitti V., Ho N.J., et al. Relationship of body iron stores to levels of serum ferritin, serum iron, unsaturated iron binding capacity and transferrin saturation in patients with iron storage disease. Acta Haematol 2002, 107:145-149.
30. Phatak P.D., Barton J.C. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients. Hematology 2003, 8:429-432.
31. Powell L.W., Dixon J.L., Ramm G.A., et al. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch Intern Med 2006, 166:294-301.
32. Kowdley K.V., Brandhagen D.J., Gish R.G., et al. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. Gastroenterology 2005, 129:494-503.
33. Barton J.C. Ferritin >1000: grand for hemochromatosis screening?. Blood 2008, 111:3309-3310.